tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DNLI Stock Latest News

Denali Therapeutics price target raised to $29 from $25 at BofA
The FlyDenali Therapeutics price target raised to $29 from $25 at BofA
16d ago
DNLI
Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)
PremiumPress Releases
Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)
17d ago
DNLI
Denali Therapeutics plans to file for accelerated approval of tividenofusp alfa
PremiumThe Fly
Denali Therapeutics plans to file for accelerated approval of tividenofusp alfa
17d ago
DNLI
Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administration
PremiumPress Releases
Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administration
1M ago
DNLI
Denali Therapeutics price target raised to $32 from $26 at Citi
PremiumThe Fly
Denali Therapeutics price target raised to $32 from $26 at Citi
2M ago
DNLI
Denali Therapeutics price target lowered to $90 from $95 at H.C. Wainwright
PremiumThe FlyDenali Therapeutics price target lowered to $90 from $95 at H.C. Wainwright
2M ago
DNLI
Denali Therapeutics reports Q2 EPS (59c), consensus (67c)
Premium
The Fly
Denali Therapeutics reports Q2 EPS (59c), consensus (67c)
2M ago
DNLI
Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
Premium
Press Releases
Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
2M ago
DNLI
Denali Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Denali Therapeutics management to meet with Oppenheimer
2M ago
DNLI
Denali Therapeutics price target raised to $29 from $28 at JPMorgan
PremiumThe Fly
Denali Therapeutics price target raised to $29 from $28 at JPMorgan
2M ago
DNLI
JPMorgan smid & large cap biotech analysts hold analyst/industry conference call
PremiumThe Fly
JPMorgan smid & large cap biotech analysts hold analyst/industry conference call
3M ago
DNLI
PTCT
Denali Therapeutics says FDA selects DNL126 for START Pilot Program
PremiumThe Fly
Denali Therapeutics says FDA selects DNL126 for START Pilot Program
4M ago
DNLI
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
PremiumPress ReleasesDenali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
4M ago
DNLI
Denali Therapeutics price target lowered to $30 from $31 at Wedbush
Premium
The Fly
Denali Therapeutics price target lowered to $30 from $31 at Wedbush
4M ago
DNLI
Denali Therapeutics reports Q1 EPS (68c), consensus (70c)
Premium
The Fly
Denali Therapeutics reports Q1 EPS (68c), consensus (70c)
5M ago
SNY
TAK
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
PremiumPress Releases
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
5M ago
DNLI
Denali completes enrollment for Regimen G of Phase 2/3 HEALEY ALS trial
PremiumThe Fly
Denali completes enrollment for Regimen G of Phase 2/3 HEALEY ALS trial
5M ago
DNLI
Denali Therapeutics price target lowered to $32 from $70 at UBS
PremiumThe Fly
Denali Therapeutics price target lowered to $32 from $70 at UBS
5M ago
DNLI
Denali Therapeutics files to sell 29.29M shares of common stock for holders
PremiumThe Fly
Denali Therapeutics files to sell 29.29M shares of common stock for holders
6M ago
DNLI
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
7M ago
ADIL
CDXS
Denali Therapeutics price target lowered to $95 from $105 at H.C. Wainwright
Premium
The Fly
Denali Therapeutics price target lowered to $95 from $105 at H.C. Wainwright
7M ago
DNLI
Denali Therapeutics to sell 3.24M shares at $17.07 in private placement
Premium
The Fly
Denali Therapeutics to sell 3.24M shares at $17.07 in private placement
7M ago
DNLI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >